Royalty Pharma Plc (RPRX)

06:21 AM

Moran Wealth Management LLC Grows Position in Royalty Pharma PLC $RPRX - MarketBeat

06:21 AM

05:13 AM

KBC Group NV Trims Holdings in Royalty Pharma PLC $RPRX - MarketBeat

05:13 AM

12:25 PM

Royalty Pharma declares $0.235 dividend - MSN

12:25 PM

Apr 18, 2026

5 Most Undervalued Biotech Stocks to Buy Right Now - Insider Monkey

Apr 18, 2026

Apr 17, 2026

Royalty Pharma PLC (NASDAQ:RPRX) Declares $0.24 Quarterly Dividend - MarketBeat

Apr 17, 2026

Apr 17, 2026

Royalty Pharma (NASDAQ:RPRX) Hits New 1-Year HighShould You Buy? - MarketBeat

Apr 17, 2026

Apr 17, 2026

Royalty Pharma stock hits 52-week high at $49.07 By Investing.com - Investing.com Canada

Apr 17, 2026

Apr 17, 2026

Royalty Pharma declares $0.235 quarterly dividend By Investing.com - Investing.com South Africa

Apr 17, 2026

Apr 17, 2026

Royalty Pharma plc Declares Dividend for the Second Quarter 2026, Payable on June 10, 2026 - marketscreener.com

Apr 17, 2026

Apr 17, 2026

Royalty Pharma declares $0.235 quarterly dividend - Investing.com

Apr 17, 2026

Apr 17, 2026

Royalty Pharma Keeps Quarterly Dividend at $0.235 per Share, Payable June 10 to Shareholders of Record as of May 15 - marketscreener.com

Apr 17, 2026

Apr 17, 2026

Royalty Pharma Declares Second Quarter 2026 Dividend - The Manila Times

Apr 17, 2026

Apr 17, 2026

Royalty Pharma plc (RPRX) Declares $0.235 Quarterly Dividend; 1.9% Yield - StreetInsider

Apr 17, 2026

Apr 17, 2026

Royalty Pharma will pay shareholders 23.5 cents a share on June 10 - Stock Titan

Apr 17, 2026

Apr 16, 2026

Royalty Pharma signs $500M co-development agreement with J&J - MSN

Apr 16, 2026

Apr 16, 2026

Sumitomo Mitsui Trust Group Inc. Acquires 166,403 Shares of Royalty Pharma PLC $RPRX - MarketBeat

Apr 16, 2026

Apr 15, 2026

Royalty Pharma to Announce Q1 2026 Results on May 6 - National Today

Apr 15, 2026

Apr 15, 2026

TD Cowen lifts PT on Royalty Pharma plc (RPRX) to $50 from $45, here’s why - MSN

Apr 15, 2026

Apr 15, 2026

Royalty Pharma : Q1 2026 Pre-Quarterly Results Communication - marketscreener.com

Apr 15, 2026

Apr 15, 2026

Royalty Pharma to Announce First Quarter 2026 Financial Results on May 6, 2026 - The Manila Times

Apr 15, 2026

Apr 15, 2026

Royalty Pharma schedules May 6 results, 8 a.m. investor webcast - Stock Titan

Apr 15, 2026

Apr 15, 2026

Foster Victor Wealth Advisors LLC Takes Position in Royalty Pharma PLC $RPRX - MarketBeat

Apr 15, 2026

Apr 14, 2026

Royalty Pharma : 2025 Corporate Responsibility Report pdf - marketscreener.com

Apr 14, 2026

Apr 14, 2026

Can Royalty Pharma (RPRX) Keep the Earnings Surprise Streak Alive? - Yahoo Finance

Apr 14, 2026

Apr 14, 2026

Robeco Institutional Asset Management B.V. Decreases Holdings in Royalty Pharma PLC $RPRX - MarketBeat

Apr 14, 2026

Apr 14, 2026

Royalty Pharma plc 8-K Filing – April 2026 Company Information and SEC Disclosure - Minichart

Apr 14, 2026

Apr 13, 2026

Royalty Pharma funds additional $250M after Phase 3 win for daraxonrasib in metastatic PDAC - TradingView

Apr 13, 2026

Apr 13, 2026

Royalty Pharma (NASDAQ: RPRX) deepens $2B daraxonrasib royalty and loan pact - Stock Titan

Apr 13, 2026

Apr 13, 2026

Royalty Pharma plc (RPRX) Proved Resilience in Q1 by Gaining 25.6% - Insider Monkey

Apr 13, 2026

Apr 13, 2026

Baillie Gifford & Co. Sells 363,734 Shares of Royalty Pharma PLC $RPRX - MarketBeat

Apr 13, 2026

Apr 12, 2026

Technical Reactions to RPRX Trends in Macro Strategies - Stock Traders Daily

Apr 12, 2026

Apr 11, 2026

Trend Review: Does Royalty Pharma plc have high return on assetsForecast Cut & Fast Exit and Entry Trade Guides - baoquankhu1.vn

Apr 11, 2026

Apr 10, 2026

[ARS] Royalty Pharma plc SEC Filing - Stock Titan

Apr 10, 2026

Apr 10, 2026

[DEF 14A] Royalty Pharma plc Definitive Proxy Statement - Stock Titan

Apr 10, 2026

Apr 10, 2026

Today's Analyst Rating Update for Royalty Pharma (RPRX) | RPRX S - GuruFocus

Apr 10, 2026

Apr 10, 2026

RPRX Stock Price, Quote & Chart | ROYALTY PHARMA PLC- CL A (NASDAQ:RPRX) - ChartMill

Apr 10, 2026

Apr 09, 2026

Assessing Royalty Pharma (RPRX) Valuation After Johnson & Johnson Autoimmune Co Funding Deal - Sahm

Apr 09, 2026

Apr 08, 2026

Royalty Pharma plc (RPRX) stock price, news, quote and history - Yahoo Finance UK

Apr 08, 2026

Apr 08, 2026

Does J&J Co-Funding Deal Around Dual-Pathway Autoimmune Candidate Recast The Bull Case For Royalty Pharma (RPRX)? - Sahm

Apr 08, 2026

Apr 07, 2026

Branded Pharmaceuticals Stocks Q4 Teardown: Royalty Pharma (NASDAQ:RPRX) Vs The Rest - Barchart

Apr 07, 2026

Apr 07, 2026

Volume Summary: Can Royalty Pharma plc scale operations efficiently2026 Highlights & Capital Protection Trading Alerts - baoquankhu1.vn

Apr 07, 2026

Apr 06, 2026

Aberdeen Group plc Acquires 98,191 Shares of Royalty Pharma PLC $RPRX - MarketBeat

Apr 06, 2026

Apr 05, 2026

Can Royalty Pharma plc deliver consistent dividends2026 Outlook & Breakout Confirmation Trade Signals - baoquankhu1.vn

Apr 05, 2026

Apr 04, 2026

RPRX Financials: Revenue Breakdown, Margins & Competitor Comparison - intellectia.ai

Apr 04, 2026

Apr 04, 2026

RPRX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Apr 04, 2026

Apr 04, 2026

Royalty Pharma Leans Into R&D And AI To Shape Future Royalties - Sahm

Apr 04, 2026

Apr 02, 2026

Royalty Pharma Plc Hits New 52-Week High at $48.74 - Markets Mojo

Apr 02, 2026

Apr 02, 2026

Royalty Pharma (NASDAQ:RPRX) CFO Terrance Coyne Sells 34,791 Shares - marketbeat.com

Apr 02, 2026

Apr 02, 2026

Royalty Pharma (RPRX) CFO-linked entities execute planned share sales - Stock Titan

Apr 02, 2026

Apr 02, 2026

Royalty Pharma plc (RPRX) latest stock news and headlines - Yahoo Finance Singapore

Apr 02, 2026

Apr 01, 2026

Royalty Pharma, Johnson & Johnson Strike $500M Autoimmune Drug Deal - Yahoo Finance UK

Apr 01, 2026